Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Indications for anticoagulants].

E Oger1, D Mottier

  • 1Département de médecine interne et pneumologie Hôpital de la Cavale-Blanche, Brest.

La Revue Du Praticien
|December 3, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The impact of the time-of-day in the administration of immunotherapy and its efficacy in patients with advanced melanoma: A retrospective observational study.

Annales de dermatologie et de venereologie·2025
Same author

Natural fermentation of fresh Jasmine flowers inspired the development of a biotechnological ingredient with global anti-ageing properties.

International journal of cosmetic science·2024
Same author

Spirometry practice by French general practitioners between 2010 and 2018 in adults aged 40 to 75 years.

NPJ primary care respiratory medicine·2023
Same author

Factors associated with early relapse of infantile haemangioma in children treated for at least six months with oral propranolol: A case-control study using the 2014-2021 French Ouest DataHub.

Annales de dermatologie et de venereologie·2023
Same author

The cardiovascular safety of oral alitretinoin: a population-based cohort study involving 19 513 patients exposed to oral alitretinoin.

The British journal of dermatology·2021
Same author

Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010-2014 French Health Insurance Data.

Journal of the European Academy of Dermatology and Venereology : JEADV·2019
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Anticoagulant therapies, including heparin and vitamin K antagonists, are crucial for preventing and treating blood clots. Direct thrombin inhibitors and danaparoid manage specific complications like heparin-induced thrombocytopenia.

Area of Science:

  • Pharmacology
  • Hematology
  • Medical Therapeutics

Context:

  • Anticoagulant medications are essential in managing and preventing thrombotic events.
  • Current therapeutic options include unfractionated heparin, low molecular weight heparins, danaparoid, vitamin K antagonists, and direct thrombin inhibitors.

Purpose:

  • To provide an overview of the various anticoagulant therapies available.
  • To highlight the primary indications and applications for each class of anticoagulant.

Summary:

  • Low molecular weight heparins are foundational for preventing venous thromboembolism in surgical patients and treating deep vein thrombosis.
  • Vitamin K antagonists are primarily used for secondary prevention of venous thromboembolism and primary prevention of arterial embolism in specific patient groups (atrial fibrillation, prosthetic valves).

Related Experiment Videos

  • Direct thrombin inhibitors and danaparoid are critical for preventing and treating thrombotic complications associated with heparin-induced thrombocytopenia.

    • Impact:

    • This information aids clinicians in selecting appropriate anticoagulant strategies based on patient conditions and risk factors.
    • Understanding the roles of different anticoagulants optimizes patient care and reduces thrombotic risks.
    • The review underscores the importance of tailored anticoagulant therapy in diverse clinical scenarios.